Enhancing Global Clinical Trials: The Impact of Travel Concierge Services on Patient Recruitment, Retention, and Compliance
Read our white paper to explore methods of overcoming travel-related barriers to recruitment, retention, and compliance.
The Vital Role of Diversity in Clinical Trials
Download our white paper The Vital Role of Diversity in Clinical Trials for a three-pronged approach to help address clinical trial enrollment and participation gaps.
Lessons Learned When Implementing a REMS Program
Download our white paper to gain insights into how a past REMS can be the best indicator of a future REMS program.
Personalized Medicine: A Primer on the Role of Pharmacogenetics and Pharmacogenomics in Oncology
This white paper discusses personalized medicine, applications of pharmacogenetics/pharmacogenomics in oncology and the positive impact they have on drug development.
Recently Approved Cell-Based Gene Therapies Demonstrate Innovation in Sickle Cell Disease Treatment
This white paper offers a comprehensive primer on the burden of SCD, the patient journey, and current and emerging treatment options.
Understanding the Natural History of Disease
Learn more about the benefits of natural history studies in drug development.
The Joint Clinical Assessment: Anticipating Challenges and Opportunities
This white paper provides an essential overview of the regulations, a brief history, and an in-depth look at the EU’s Health Technology Assessment Regulation 2021/2282.
Gain Strategic Insights by Linking Clinical Trial Data to Real World Data
Read our white paper to explore how integrating RWD/RWE with clinical trial data can overcome challenges and enhance regulatory submissions.
The FDA Expands the Types of Confirmatory Evidence Sources to Support Drug Effectiveness Studies
Learn how the inclusion of real-world data (RWD) and evidence from natural history studies can improve your integrated evidence strategy.
Understanding the Importance of Utilizing Social Determinants of Health
This white paper explores using the elements of social determinants of health (SDOH) to create optimal patient services program design.
